International pharma companies eye Korea as vaccine production hub: PM
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
New Prime Minister Kim Boo-kyum on Tuesday hinted that more multinational vaccine makers could be seeking a production base in Korea.
“Korea is one of the few countries in the world that, as you know, can produce vaccines when combined with various technologies of the US,” he told reporters in his first press briefing on Tuesday afternoon.
“Many multinational pharmaceutical companies, Pfizer, Johnson & Johnson, Janssen and Moderna, want to form vaccine partnerships with Korea,” he said, adding that there are high expectations for a tie-up to materialize from the upcoming summit on Friday.
Kim also expressed hopes that the summit would serve as an opportunity to further enhance the Korea-US alliance.
Following US President Joe Biden’s remarks that the nation would send an additional 20 million COVID-19 vaccines abroad by the end of June, some local media reports, citing sources, said Korea could become the “first negotiators” and expect a positive outcome of the consultation.
When asked whether securing vaccines will be on the agenda during the Friday summit, Kim stopped short of any confirmation.
“I understand that various (related) efforts are ongoing, but I don’t know exactly whether (securing vaccines) will be on the summit agenda and in what way if it does,” Kim said.
By Shin Ji-hye (shinjh@heraldcorp.com)
<ⓒKoreaHerald(www.koreaherald.com)무단전재 및 재배포 금지>
Copyright © 코리아헤럴드. 무단전재 및 재배포 금지.